Acts and Regulations

2014-142 - General

Table of contents
Full text
Current to 1 January 2024
NEW BRUNSWICK
REGULATION 2014-142
under the
Prescription Monitoring Act
(O.C. 2014-367)
Filed August 18, 2014
Under section 18 of the Prescription Monitoring Act, the Lieutenant-Governor in Council makes the following Regulation:
Citation
1This Regulation may be cited as the General Regulation - Prescription Monitoring Act.
Definition of “Act”
2In this Regulation, “Act” means the Prescription Monitoring Act.
Classes of drugs
Repealed: 2025, c.18, s.2
2025, c.18, s.2
3Repealed: 2025, c.18, s.2
2025, c.18, s.2
Access to information
4For the purposes of section 7 of the Act, a participant who makes a request to the Director shall have access to the following information:
(a) a summary report of members’ prescribing privileges that have been revoked, suspended or otherwise altered by a licensing authority under subsection 11(1) of the Act; and
(b) a summary report of the participant’s prescribing and dispensing patterns with respect to monitored drugs.
2025, c.18, s.2
Information network alerts
Repealed: 2025, c.18, s.2
2025, c.18, s.2
5Repealed: 2025, c.18, s.2
2025, c.18, s.2
Advisory committee mandate
6(1)Each member of the advisory committee, excluding the Director, shall be appointed for a term of up to three years.
6(2)The term under subsection (1) is renewable but no member shall serve more than three consecutive terms in addition to any term required to fill a vacancy under subsection 7(1).
6(3)A member of the advisory committee who dies or resigns from office ceases to be a member of the advisory committee on the date of their death or on the day the Minister receives their resignation, as the case may be.
6(4)Despite subsection (2), a member of the advisory committee whose term has ended may remain in office until the member is reappointed or replaced.
2025, c.18, s.2
Vacancy
7(1)If the term of a member of the advisory committee ends, the Minister shall reappoint the person or replace the person to fill the vacancy.
7(1.1)If a member of the advisory committee dies or resigns, the Minister may appoint a person to fill the vacancy for the balance of the term of the member.
7(2)A vacancy on the advisory committee does not impair the capacity of the advisory committee to act.
2025, c.18, s.2
Meetings and quorum
8(1)All members of the advisory committee shall be entitled to vote at meetings except the Director and any member who is employed in the Department of Health.
8(2)A majority of the voting members present at a meeting of the advisory committee constitutes a quorum.
8(3)In the event of a tie vote at a meeting, the chair shall cast the deciding vote.
8(4)The members of the advisory committee shall elect from among the voting members a chair for a term of up to three years and a vice-chair for a term of up to two years.
8(5)Subject to subsection (6), the chair or, in the chair’s absence, the vice-chair shall preside at the meetings.
8(6)If the chair and vice-chair are absent from a meeting, the voting members present shall elect from among themselves a member to preside at the meeting.
8(7)In the absence of the chair, the vice-chair or the member elected under subsection (6) shall perform the duties and exercise the powers of the chair.
8(8)The advisory committee shall meet at least once every fiscal year.
8(9)The advisory committee shall ensure that minutes are taken at each meeting and that the minutes are submitted to the Minister once they are approved by the advisory committee.
8(10)The advisory committee may invite experts and professionals to attend and provide advice at a meeting if the advisory committee considers it necessary.
2025, c.18, s.2
Conflict of interest
9(1)A member of the advisory committee is in a conflict of interest if, in the opinion of the chair,
(a) the member has an interest in the matter, distinct from an interest arising from their functions as a member,
(b) the member has a direct or indirect pecuniary interest in the matter,
(c) a parent, spouse, common-law partner, brother, sister or child of the member has an interest in the matter, or
(d) the member is an officer, employee or agent of a corporation, an unincorporated association or any other association of persons that has an interest in the matter.
9(2)If a member of the advisory committee is in a potential conflict of interest, the member shall disclose to the advisory committee the nature and extent of the interest either in writing or by requesting to have it entered in the minutes of the meeting.
9(3)A member of the advisory committee shall disclose a potential conflict of interest
(a) at the meeting at which the matter giving rise to the conflict of interest is considered, or
(b) if the member is not in a conflict of interest at the time described in paragraph (a), at the first meeting that is held after the conflict of interest arises.
9(4)If, in the opinion of the chair, a member of the advisory committee is in a conflict of interest, the chair may
(a) exclude the member from the meeting, or
(b) limit the participation of the member at the meeting.
2025, c.18, s.2
Remuneration and reimbursement of expenses
Repealed: 2025, c.18, s.2
2025, c.18, s.2
10Repealed: 2025, c.18, s.2
2016, c.37, s.147; 2025, c.18, s.2
Patient monitoring agreement
Repealed: 2025, c.18, s.2
2025, c.18, s.2
11Repealed: 2025, c.18, s.2
2025, c.18, s.2
Commencement
12This Regulation comes into force on September 1, 2014.
N.B. This Regulation is consolidated to June 6, 2025.